Legal Representation
Attorney
Noel K. Egnatios, Esq.
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 7, 2013 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 7, 2013 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 12, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 11, 2012 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 15, 2012 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 8, 2012 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 15, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 12, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 10, 2011 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 10, 2011 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 10, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 7, 2011 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 12, 2011 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 12, 2011 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 8, 2011 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 7, 2011 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 9, 2011 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 9, 2011 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 9, 2011 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 9, 2011 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 9, 2011 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 28, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 27, 2010 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Oct 26, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 22, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical compositions and preparations for use in therapeutics for human, animal and livestock diseases, namely, use for cardiovascular disease, metabolic disease, autoimmune disease, diabetes, obesity, inflammatory disease, vascular disease, dermatological disease, ocular disease, hematological disease, neurological disease, gastrointestinal disease, respiratory disease, viral and infectious disease, cancer, allergies, allograft rejection, genetic disorders, diseases of the musculoskeletal and nervous system, analgesics and wound healing; pharmaceutical compositions and preparations for the diagnosis, prophylaxis and treatment of human, animal and livestock diseases, namely, cardiovascular disease, metabolic disease, autoimmune disease, diabetes, obesity, inflammatory disease, vascular disease, dermatological disease, ocular disease, hematological disease, neurological disease, gastrointestinal disease, respiratory disease, viral and infectious disease, cancer, allergies, allograft rejection, genetic disorders, diseases of the musculoskeletal and nervous system, analgesics and wound healing; vaccines; pharmaceutical compositions and preparations in the nature of contrast media for use with medical imaging equipment; biological reagents for use in clinical medical and non-clinical medical tests for the diagnosis and measurement of disease progression in human, animal and livestock diseases; biological reagents for use in clinical medical and non-clinical medical imaging
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a hexagon design comprised of three interlocking chevrons and the stylized wording "ANAPHORE".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005